Technavio predicts that the intrauterine contraceptives market will grow by USD 799.85 million from 2020 to 2025 | National News

NEW YORK, January 13, 2022 /PRNewswire/ — If we look at historical data ahead of the base year, the healthcare device industry faced consolidation in 2019 as mid-size and large manufacturers aimed to enter new markets, expanding the brand portfolio by adding new product/service verticals expand and acquire new technologies through mergers and acquisitions (M&A).

Highlights of the Intrauterine Contraceptive Devices market report:

  1. Market Growth 2021-2025: $799.85 million
  2. Growth Momentum & CAGR: Accelerating at a CAGR of almost 4%
  3. YoY growth (%): 3.25%
  4. Performing market contribution: North America at 33%
  5. Main buyer countries: USA, Germany, China, France, and Japan

Would you like more data and information not included in this report? Contact our analysts and get this report customizable to your needs. Talk to an analyst.

Regional market analysis

With 33% of the growth comes from North America, this region will witness a rapid growth rate in 2021-2025. The long-term effectiveness and increased acceptance will significantly impact the intrauterine contraceptive market growth in this region. The US leads the market North America. The presence of local market players, supportive government initiatives, high awareness and technological innovations such as postpartum and reusable IUDs are driving the market growth in the United States. According to the Centers for Disease Control and Prevention (CDC), nearly half of pregnancies in the United States are unwanted. Therefore, the country experiences a high acceptance of intrauterine devices among women. Currently, the US market has four IUDs, namely Mirena, Skyla, LILETTA and Kyleena, and one copper IUD, namely PARAGARD. In Canada, Copper Coils are available with Mirena, Jaydess, and Kyleena.

More information on the regional market: Request a free sample report.

Key vendors and vendor strategies

AbbVie Inc., Bayer AG, DKT International, EUROGINE SL and Laboratoire HRA Pharma SAS are some of the major players in the intrauterine contraceptive market.

Vendors in the market are constantly focused on launching new products with innovative technologies to strengthen the product portfolio and maintain their position among the global intrauterine contraceptives. Some of the key offerings from major providers are listed below:

  • AbbVie Inc. – The company offers intrauterine contraceptives under the LILETTA brand.
  • Bayer AG – The Company offers intrauterine contraceptives under the Mirena brand.
  • DKT International – The Company offers intrauterine contraceptives under the SafeLoad and Silverline brands.

Download our free sample report to get a brief picture of various other providers and their strategies.

Important market drivers

Our analysts have detailed the information related to the key market drivers and their impact on the intrauterine contraceptives market.

  • Rising rate of unwanted pregnancies and unwanted abortions:

The rising incidence of unwanted pregnancies is expected to contribute to the growth of the global intrauterine contraceptive market. Unwanted pregnancy is one of the most pressing public health issues and a significant global reproductive health problem, imposing a significant socioeconomic burden on society and individuals. According to the World Health Organization (WHO), almost half of pregnancies among teenage girls between the ages of 15 and 19 in developing countries are unwanted. The introduction of contraceptive methods can reduce the rate of such pregnancies. The likelihood of pregnancy decreases significantly with the use of IUDs. The increasing prevalence of unwanted abortions is also likely to increase demand for IUDs, leading to growth in the market. A large number of unwanted abortions is driving the need for more effective contraceptives.

To learn some other market drivers, trends and challenges.

Download our free sample report

Related reports:

  • Polysomnography Devices Market by Application and Geography – Forecast and Analysis 2021-2025: The market share of polysomnography devices is expected to increase by $136.42 million from 2020 to 2025, and the growth momentum of the market will accelerate at a CAGR of 5.71%. Download free sample report
  • Biomaterials Market by Type and Geography – Forecast and Analysis 2022-2026: Biomaterials market share is expected to increase by $12.82 billion from 2021 to 2026, and the growth momentum of the market will accelerate at a CAGR of 6.04%. Download free sample report

Intrauterine Contraceptives Market Scope

report coverage

details

page number

120

base year

2020

forecast period

2021-2025

Growth Dynamics & CAGR

Accelerate with a CAGR of 4%

Market growth 2021-2025

$799.85 million

market structure

fragmented

YoY Growth (%)

3.25

Regional Analysis

North America, Europe, APAC and ROW

make a market contribution

North America at 33%

Important consumer countries

USA, Germany, China, France and Japan

competitive landscape

Leading companies, competitive strategies, levels of consumer engagement

company profiled

AbbVie Inc., Bayer AG, DKT International, EUROGINE SL, Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Pregna International Ltd., Prosan International BV, SMB Corp. of India and The Cooper Companies Inc.

market dynamics

Stem Market Analysis, Market Growth Drivers and Obstacles, Fast Growing and Slow Growing Segment Analysis, Impact of COVID-19 and Future Consumer Dynamics, Market Condition Analysis for Forecast Period,

customization area

If our report does not contain the data you are looking for, you can contact our analysts and have segments adjusted.

about us

Technavio is a leading global technology research and consulting firm. Her research and analysis focuses on trends in emerging markets and provides actionable insights that help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies and spanning 50 countries. Their customer base consists of companies of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s extensive reporting, extensive research and actionable market insights to identify opportunities in existing and potential markets and to assess their competitive position in changing market scenarios.

Contact

Technavio Research

Jess Maida

Media and Marketing Executive

United States: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]

Website: www.technavio.com/

Watch original content to download multimedia: https://www.prnewswire.com/news-releases/technavio-forecasts-intrauterine-contraceptive-devices-market-to-grow-by-usd-799-85-million -from-2020-to-2025–301459517.html

SOURCE Technavio

Comments are closed.